Drug Shortage Report for JORVEZA
Report ID | 147948 |
Drug Identification Number | 02493675 |
Brand name | JORVEZA |
Common or Proper name | Jorveza 1mg |
Company Name | AVIR PHARMA INC. |
Market Status | MARKETED |
Active Ingredient(s) | BUDESONIDE |
Strength(s) | 1MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL |
Packaging size | 90 |
ATC code | A07EA |
ATC description | INTESTINALANTIINFLAMMATORY AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2021-11-01 |
Actual start date | 2022-01-21 |
Estimated end date | 2022-01-21 |
Actual end date | 2022-01-21 |
Shortage status | Resolved |
Updated date | 2022-01-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 660 BOULEVARD INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2022-01-22 | English | Compare |
v8 | 2022-01-21 | French | Compare |
v7 | 2022-01-21 | English | Compare |
v6 | 2021-12-22 | French | Compare |
v5 | 2021-12-22 | English | Compare |
v4 | 2021-11-02 | English | Compare |
v3 | 2021-10-25 | French | Compare |
v2 | 2021-10-25 | English | Compare |
v1 | 2021-10-25 | English | Compare |
Showing 1 to 9 of 9